The euphoria that greeted Gerresheimer’s €1.5bn divestment plan has faded noticeably. The pharmaceutical packaging specialist closed Friday’s session at €26.34, down 0.83 percent on the day and 4.57 percent lower on the week. Over a 30-day horizon, the shares have shed 9.92 percent of their value — eroding a meaningful chunk of the 12.5 percent surge triggered on July 29, when the company unveiled its agreement to sell two business units to a consortium advised by Apax Partners LLP.
That initial jump reflected genuine relief. The disposal of Centor US Holding and the global Primary Packaging Plastics (PPP) operations, carrying a combined enterprise value of roughly €1.5bn, hands management a powerful tool…